You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

List of Excipients in Branded Drug FEELSHION LAVENDER MAGNESIUM


✉ Email this page to a colleague

« Back to Dashboard


Excipient Strategy and Commercial Opportunities for FEELSHION LAVENDER MAGNESIUM

Last updated: February 28, 2026

What Is the Composition and Role of Excipients in FEELSHION LAVENDER MAGNESIUM?

FEELSHION Lavender Magnesium is a dietary supplement combining magnesium with lavender extracts, marketed primarily for relaxation and sleep support. The formulation relies on specific excipients to ensure product stability, bioavailability, and consumer acceptability.

Common excipients for such products include:

  • Fillers: Microcrystalline cellulose to add bulk
  • Binders: Povidone to maintain tablet integrity
  • Disintegrants: Croscarmellose sodium to facilitate dissolution
  • Lubricants: Magnesium stearate to prevent sticking during manufacturing
  • Flavoring agents: Lavender extract or flavorings for sensory appeal

The choice of excipients influences manufacturing parameters, shelf-life, and sensory perception.

How Do Excipients Impact Formulation and Marketability?

Excipients can impact:

  • Product stability: Protect active ingredients from moisture, oxygen, or light. For magnesium, excipients like magnesium oxide may be used to prevent degradation.
  • Bioavailability: Disintegrants and binders expedite dissolution, enhancing absorption.
  • Sensory profile: Flavors and sweeteners improve consumer acceptance, particularly in oral supplements.
  • Regulatory compliance: Certain excipients are preferred due to established safety profiles and easier regulatory approval.

The strategic selection of excipients can differentiate the product, enabling claims such as "rapid absorption" or "long shelf-life."

What Are the Key Commercial Opportunities Linked to Excipient Choice?

1. Premium Formulation Development

Incorporating natural, organic, or gluten-free excipients enables positioning in high-end markets. Consumers increasingly prefer clean-label products.

2. Extended Shelf-Life

Selecting excipients with moisture and oxygen barriers extends product shelf-life, reducing waste and supply chain costs.

3. Delivery System Innovation

Formulating as lozenges, gummies, or effervescent tablets with tailored excipients opens new sectors, such as functional foods or beverages.

4. Regulatory Differentiation

Using excipients with well-documented safety profiles under regulatory frameworks (e.g., FDA, EMA) simplifies approval and reduces compliance costs.

5. Manufacturing Scalability

Choosing excipients compatible with high-speed production lines lowers manufacturing costs and enhances supply chain efficiency.

How Do Market Trends Influence Excipient Strategies?

  • Clean-label products: Demand for non-artificial excipients (e.g., plant-based binders) creates opportunities for differentiated products.
  • Functional delivery systems: Liposomal or MicroEncapsulation techniques, involving excipients, improve magnesium stability and bioavailability.
  • Personalized nutrition: Formulations tailored to dietary restrictions influence excipient choices, favoring allergen-free or allergen-avoidant materials.

What Are the Regulatory Considerations?

  • Safety and documentation: Regulatory agencies require detailed safety data for excipients.
  • Excipients list: Use of generally recognized as safe (GRAS) excipients expedites approval.
  • Novel excipients: Involve longer approval timelines and higher costs.

Potential for Collaborative Development

Partnerships with excipient suppliers specializing in natural or novel excipients can foster product differentiation. Joint R&D reduces time to market and ensures regulatory compliance.

Summary Table of Excipients and Commercial Impacts

Excipients Type Function Commercial Opportunity
Microcrystalline cellulose Filler/binder Supports premium, clean-label positioning
Croscarmellose sodium Disintegrant Improves dissolution, supporting rapid absorption claims
Magnesium stearate Lubricant Enhances manufacturing efficiency, lowering costs
Lavender flavoring Sensory appeal Differentiates with natural flavor, targeting niche markets
Plant-based binders Natural, gluten-free Meets consumer demand for clean-label products

Key Takeaways

  • Excipient selection directly influences product stability, bioavailability, sensory perception, and regulatory compliance.
  • Innovative excipient strategies enable market differentiation via clean-label, extended shelf-life, and novel delivery systems.
  • Trends toward natural ingredients and personalized nutrition drive demand for excipients aligned with these values.
  • Regulatory considerations prioritize GRAS or well-documented excipients to streamline approval.
  • Collaboration with specialist excipient suppliers supports product innovation and cost management.

FAQs

1. How does excipient choice affect the bioavailability of magnesium in FEELSHION Lavender Magnesium?
Excipients like disintegrants and solubilizers improve magnesium breakdown and absorption, enhancing efficacy.

2. What excipients are most suitable for clean-label supplement formulations?
Natural binders (e.g., cellulose), plant-based flavors, and non-synthetic stabilizers align best with clean-label requirements.

3. Can excipients be used to enhance the sensory experience of lavender magnesium supplements?
Yes, flavors, sweeteners, and natural aromas improve taste and aroma, increasing consumer acceptance.

4. Are there regulatory restrictions on excipients in dietary supplements?
Yes, excipients must comply with safety guidelines, such as FDA GRAS status, to facilitate approval.

5. What trends are influencing excipient innovation in this market?
Demand for natural ingredients, delivery system improvements, and personalized products drive innovation in excipient selection.


References

  1. U.S. Food and Drug Administration. (2021). Inactive Ingredients Database. Retrieved from https://www.fda.gov/cosmetics/cosmetic-products/inactive-ingredients-database
  2. Rowe, R. C., Sheskey, P. J., & Quinn, M. E. (2009). Handbook of Pharmaceutical Excipients (6th ed.). Pharmaceutical Press.
  3. European Medicines Agency. (2022). Guidelines on excipients in medicinal products. EMA/CHMP/CVMP/SWP/169430/2012.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.